Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Therapy in Parkland Burn Fat, Boost Recovery, Look Younger Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law Gray Market Peptides: So Much Hype, So Little Data